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Bioaccessibility of apigenin from Mangifera indica (Water Lily Var.) during in 
vitro gastrointestinal digestion
Abstract
The bioaccessibility property of apigenin from Mangifera indica (Water Lily var.) was 
investigated using in vitro gastrointestinal digestion model. Two digestion stages were 
simulated namely the gastric and small intestinal digestion by using different enzymes and 
physiological conditions that mimicked the digestion process. Following digestion, the 
bioaccessible apigenin was analysed using HPLD-DAD-MS. Results showed that the apigenin 
fraction in intestinal phase was higher than in gastric phase with amounts 1.03 ± 0.35 mg/100 
g DW and 0.50 ± 0.08 mg/100 g DW, respectively. After 1 h exposure to gastric juice, the 
bioaccessibility of apigenin was 20.26 ± 3.06% with 79.74 ± 3.06% losses during the digestion, 
whereas in intestinal phase, the percentage of bioaccessibility significantly increased to 41.53 
± 13.99% and 58.47 ± 13.99% losses after 2 h treatment with pancreatin. It was concluded that 
the apigenin in Water Lily mango became bioaccessible, suggesting the absorption possibility 
of the compound in the upper part of intestine, which can lead to the health-related outcomes.
Introduction
Over the past decades, numerous studies on 
phytochemicals have considered their bioaccessibility 
using the latest physiological knowledge and 
technological breakthroughs (Briones-Labarca et 
al., 2011). Bioaccessibility is defined as the fraction 
of a compound released from the food matrix and 
solubilised during digestion that is potentially 
available for absorption (Alminger et al., 2014; 
Carbonell-Capella et al., 2014). It is a digestive 
transformation of food into small components used 
for assimilation, absorption into intestinal epithelial 
cells, and subsequently the presystemic metabolism 
(Heaney, 2001). The amount of bioaccessible 
fraction may be equal or less than the amount of the 
compound released from the food (Stahl et al., 2002). 
Studies on bioaccessibility usually involve the in 
vitro digestion method, generally simulating gastric 
and small intestinal digestions, and sometimes 
followed by Caco-2 cells uptake (Courraud et al., 
2013). The scientific community has developed 
different digestion models which mimic the 
physiological and physicochemical conditions of 
the human gastrointestinal tract to measure the 
release of polyphenols from food matrices during 
digestion (Hur et al., 2011). Several studies have 
reported different trends in the polyphenol profile 
after undergoing gastrointestinal digestion (Ortega et 
al., 2009). During gastric digestion, the stability of 
certain polyphenol compounds may not change but 
increase as a result of the low pH after the digestion 
process. According to Bouayed et al. (2012), some 
polyphenols are unstable and poorly absorbed under 
the gastrointestinal environment.
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Several studies have reported different trends 
in the polyphenol profile after the gastrointestinal 
digestion process (Ortega et al., 2009). Also, 
some studies have determined the stability and 
transformation of polyphenols during digestion, 
either by using synthesised compounds or by 
extraction from the food sources (Spencer et al., 
2000; Rios et al., 2002). According to Maqueda 
(2012), the properties of polyphenolic compounds 
in a food matrix are not the same as they are tested 
as single components. During the digestion process, 
the effect exerted by the food matrix may change 
certain essential parameters such as the stability of 
compounds during digestion or bioavailability. There 
are some recent studies reporting the effect of food 
matrix on bioaccessibility of phytochemicals during 
digestion (Phan et al., 2019).
Water Lily is one of the mango varieties found 
in Malaysia, Thailand and Indonesia. The fruit has 
a sweet taste, juicy, and firm texture but sometimes 
a little mushy. It is a delicious seasonal fruit that 
is generally available between June to August 
and November to February. Apigenin, a phenolic 
compound belonging to the flavone class that present 
in Water Lily mango, has been studied for to determine 
its bioaccessibility. It has gained much attention in 
recent years due to its benefits and health promotions, 
which are relatively non-toxic and non-mutagenic. 
Apigenin is commonly used in traditional medicines 
and herbal supplements for many pharmacological 
activities, including antioxidant properties and its 
role in free scavenging activity (Madunić et al., 
2018), anti-inflammatory effects (Funakoshi-Tago 
et al., 2011), and growth inhibitory properties in 
several cancer lines including colon, skin (Tong et 
al., 2007) and pancreas (Ujiki et al., 2006). In order 
to associate apigenin consumption to any potential 
health benefits, it is necessary to first understand how 
mango and apigenin are digested as this will affect 
the bioavailability and bioactivity of the compound 
in the human body.
To date, limited data is available indicating on 
how apigenin is digested and metabolised through 
the gastrointestinal tract. Therefore, the purpose of 
the present work was to evaluate the bioaccessibility 
of apigenin in Water Lily mango through an in vitro 
gastrointestinal digestion model. The amount of 
bioaccessible fraction obtained from the digestion 
model was analysed using HPLC-DAD tandem mass 
spectrometry.
Materials and methods
Chemicals
Apigenin standard, pepsin (P-7000, from porcine 
stomach mucosa), pancreatin (P-1750, from porcine 
pancreas), and bile extract (B-8631, from porcine) 
were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA). Phosphoric acid, hydrochloric 
acid, sodium hydroxide and HPLC-grade solvents 
were obtained from Fisher Scientific (Loughborough, 
UK).
Preparation of extract 
Water Lily mango pulp extract (WLPE) was 
prepared following the method described by Ferreres 
et al. (2008) with slight modifications. The sample 
was cut into small pieces then freeze-dried at -40°C 
for 28 h, tempered for 1 h in liquid nitrogen, and 
freeze-dried again for 24 h under high vacuum 
conditions (0.04 mbar). Then, 3 g of freeze-dried 
sample was homogenised in 20 mL of 80% methanol 
using homogeniser. The mixture was sonicated 
for 30 min at 30°C in ultrasonic bath, followed by 
centrifugation at 12,000 g for 15 min at 5°C, and 
filtered through a Whatman filter paper No. 1. The 
extract was concentrated to dryness in a rotary 
evaporator. Then 100 mg of extract was mixed with 
10 mL of 0.9% saline solution. All solutions were 
freshly prepared and immediately subjected to in 
vitro digestion following preparation.
In vitro gastric digestion  
The WLPE was subjected to in vitro gastric 
digestion procedure, following the previously 
published method (Andlauer et al., 2000) with minor 
modifications. The digestion by gastric phase was 
initiated by adjusting the pH of solution to 1.9 with 
1 mol/L HCL. The sample was pre-heated in a water 
bath at 37°C for 5 min, then 2 mL of pepsin solution 
(17.5 g/L in 0.1 mol/L HCl) was added. The mixture 
was purged with nitrogen and container was tightly 
sealed. Incubation was carried out at 37°C for 1 h 
with continuous stirring. At the end of the gastric 
digestion, the aliquot was centrifuged (3,000 rpm at 
4°C) for 30 min and the supernatant was analysed 
using HPLC-DAD tandem mass spectrometry.
In vitro intestinal digestion 
The sample from gastric digestion underwent 
intestinal digestion by adjusting the pH to 6.5 with 1 
mol/L NaOH with the addition of 2 mL of pancreatin 
(7 g/L) and bile salts (7.4 g/L) in 0.9% saline solution 
as described by Andlauer et al. (2000). Subsequently, 
oxygen was removed by blowing the mixture with 
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nitrogen then incubated in darkness for 2 h at 37°C 
with continuous stirring. Digestion process was 
stopped by cooling the mixture on ice bath and sample 
volume was made up to 20 mL with 0.9% NaCl. The 
sample was centrifuged at 3,000 rpm for 30 min at 
4°C, and the supernatant was analysed using HPLC-
DAD tandem mass spectrometry.
Determination of bioaccessible apigenin by HPLC-
DAD analysis 
To determine the bioaccessible apigenin, 1 mL of 
digested sample was taken after gastric and intestinal 
digestions, and mixed with 100 µL of 1% ascorbic 
acid and 0.28% phosphoric acid. The identification of 
apigenin fraction was carried out using HPLC (1100 
series, Agilent Technologies, Germany) equipped 
with a diode array detector (DAD). The absorption 
spectrum was recorded at 280 nm. The system was 
equipped with Lichrosper C18 column (250 × 4 
mm, i.d., and particle size 5 µm). The mobile phase 
consisted of 0.5% (v/v) acetic acid in water (eluent A), 
and 100% methanol (eluent B), and gradient program 
was as follows: 0% to 90% B (0 - 20 min), 90% B 
isocratic (20 - 25 min), 90% to 0% B (25 - 30 min) at 
a flow rate of 0.6 mL/min. The injection volume was 
20 µL. Quantification of apigenin was performed by 
recording the absorbance in a chromatogram analysis 
relative to external standard in the range 20 - 100 µg/
mL at 280 nm. Apigenin compound was identified 
by chromatographic comparison with authentic 
synthetic standard.
Analysis of bioaccessible apigenin by LC-ESI-
QTOF-MS
Analysis of apigenin fraction in the extract 
was carried out using Quadrupole Time-of-Flight 
(Q-TOF) mass spectrometer (Agilent Technologies 
Inc., Palo Alto, CA) equipped with electrospray 
ionisation (ESI) source. The mass spectra recorded 
from m/z 50 to 1100, in negative ionisation mode. 
High purity nitrogen applied was nebulising (30 psi) 
and drying gas (10 L/min). The gas and vaporiser 
temperature were set at 325°C, and the scan source 
parameters were capillary voltage and fragmenter 
with 4 kV and 175, respectively. Phenolic compounds 
were identified by comparing their retention time and 
absorption spectra with those obtained with reference 
standards as well as based on their mass spectra.
Bioaccessibility calculations 
The estimation of the bioaccessibility of apigenin 
was calculated by analysing its concentration in the 
supernatant recovered after the in vitro simulated 
gastrointestinal digestion (Rodríguez-Roque et 
al., 2015). The percentage of bioaccessibility was 
calculated as below:
Where, Adigested = concentration of apigenin in the 
supernatant, and Anon digested = amount of apigenin in 
the extract.
Statistical analysis
Data were expressed as means ± standard 
deviation. All experiments were carried out three 
times. The statistical analysis was performed using 
the SPSS statistical package for windows (Version 
21.0; SPSS Inc., Chicago, IL, USA). t-test analysis 
was used to determine the significant differences with 
limit of probability of significance fixed at p < 0.05. 
Results and discussion
Identification of bioaccessible apigenin by HPLC-
DAD
In order to determine the fraction of apigenin 
following simulated digestion, HPLC-DAD analysis 
of digested sample was conducted. The digestion 
Figure 1. HPLC chromatograms of apigenin detected at 
25.1 digestion time at 280 nm from: (A) Water Lily mango 
pulp extract (WLPE) subjected to 1 h of simulated gastric 
digestion with HCl-pepsin at pH 1.9; (B) Water Lily 
mango pulp extract (WLPE) after further 2 h of digestion 
with pancreatin-bile salts at pH 6.5.
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of the extract was performed for 1 h under stomach 
acidic condition and 2 h under intestinal condition. 
Figure 1 shows the HPLC chromatogram of apigenin 
compound after gastric and intestinal in vitro 
digestions. At 280 nm, the apigenin compound was 
observed in extract both at gastric and intestinal 
phase at 25.1 digestion time. The results obtained for 
digested sample were confirmed by comparing the 
retention time and mass spectra with pure commercial 
compound.
The determination of bioaccessibility requires 
quantitative analysis of polyphenols: (i) the total 
amount obtained in extract, and (ii) the concentration 
in each gastric and intestinal digestion. The apigenin 
standard was also subjected to the same in vitro 
conditions and results were similar as in the extract. 
One particular finding was that the signal intensity of 
digested sample at intestinal phase was significantly 
higher than gastric phase, indicating that the 
concentration of bioaccessible apigenin was higher 
during digestion in the intestinal environment. This 
could probably be explained by the longer incubation 
time during intestinal environment along with the 
influence of intestinal enzyme on the complex food 
matrix resulting in the release of apigenin bound 
to the matrix (Carbonell‐Capella et al., 2014). 
Meanwhile, Blancas-Benitez et al. (2018) claimed 
that the gastrointestinal tract acted as an extractor 
that liberates the polyphenolic compounds from food 
matrices.
Analysis of bioaccessible apigenin by ESI-QTOF-
MS 
The confirmation of apigenin compound in extract 
following in vitro simulated gastrointestinal digestion 
achieved by ESI-QTOF-MS is presented in Figure 2. 
Results showed that the deprotonated parent ion peak 
at m/z 269.0537 was the characteristic of apigenin 
compound in digested sample. Further confirmation 
with apigenin standard (m/z 269.0465) was also 
conducted and results indicated the same ion mass 
for both standard and bioaccessible fractions.
ESI-QTOF-MS facilitates the identification and 
characterisation of known and unknown constituents 
based on their molecular formula, exact mass 
measurements, and MS ion. Table 1 depicts the 
bioaccessible fraction of apigenin in extract identified 
by LC-ESI-MS following in vitro gastrointestinal 
digestion. As seen in Table 1, the parent ion peak of 
bioaccessible fraction of apigenin was similar to the 
parent ion peak of pure apigenin and theoretical mass 
ion of apigenin at 269.0537, 269.0465, and 270.0528, 
respectively. Thus, these data strengthen the fact that 
bioaccessible apigenin was observed at retention 
time of 25.1 during the simulated gastrointestinal 
digestion. Bergantin et al. (2017) identified the 
presence of apigenin glucoside in red chicory (leafy 
vegetable) using HPLC-MS/MS with m/z 431 after 
undergoing gastrointestinal digestion.
In vitro gastrointestinal digestion of apigenin
The concentration of bioaccessible apigenin 
following in vitro simulated gastrointestinal digestion 
was expressed as mg/100 g of dried weight, and 
is depicted in Figure 3. The result showed that the 
concentration of bioaccessible apigenin significantly 
decreased from 2.48 ± 0.09 mg/100 g DW to 0.5 ± 
0.08 mg/100 g DW following digestion in acidic 
gastric condition. There was an increase (1.03 ± 0.35 
mg/100 g DW) of about 51.46% (p < 0.05) following 
2 h exposure in the intestinal environment. Despite 
Table 1. Mass spectrometry analysis of apigenin in Water Lily mango pulp extract (WLPE) and commercial apigenin 
standard after in vitro simulation gastrointestinal digestion.
Compound Retention time (min) Theoretical [M-H]- (m/z) Experimental [M-H]- (m/z) Abundance
Apigenin in WLPE 25.1 269.0467 269.0537 6379.98
Apigenin standard 25.1 269.0467 269.0465 123143.67
Figure 2. LC-ESI-MS spectra acquired in negative full scan 
mode corresponding to the [M-H]- ions of: (A) apigenin 
compound in Water Lily mango pulp extract (WLPE); (B) 
commercial apigenin standard compound after in vitro 
simulation gastrointestinal digestion.
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noticeable degradation during the digestion process, 
apigenin compound was still present in both gastric 
and intestinal juices (Xie et al., 2013). 
The gastric phase revealed the reduction of 
apigenin concentration in WLPE, in comparison with 
the initial amount, believed to occur due to the less 
stability of apigenin in digestive fluid that can affect 
the concentration available to the intestinal epithelia 
(Neilson et al., 2007). Digestion process can alter 
and degrade the phenolic structure, thereby affecting 
the bioaccessibility and possible beneficial effects 
(Antunes-Ricardo et al., 2017). The increase in amount 
of bioaccessible apigenin after the 2-h intestinal 
digestion suggested that despite mild alkaline 
conditions, the protein-polyphenol interactions were 
typically weak thus reversed reactions may occur 
(Santos-Buelga and Scalbert, 2000). Hence, part of 
the bound apigenin was released from the protein-
polyphenol complex, which then made the fraction 
become more bioaccessible.
Meanwhile, the measurement of biological 
parameter on the in vitro digestion model is the 
percentage of bioactive compounds absorbed during 
digestion process (Gil-Izquierdo et al., 2002; Ortega 
et al., 2009). In the present work, the bioaccessibility 
of phenols was approximated in vitro using the 
centrifugation technique instead of semipermeable 
cellulose membrane or filtration methods. This 
technique involves the separation of soluble fraction 
from the digested sample. The determination of 
bioaccessibility of apigenin in WLPE was based 
on the amount of solubilised component during the 
digestion process.
In vitro gastrointestinal digestion is a model 
applying physiologically based conditions such as 
the chemical composition of digestive fluids, pH, 
and residence time typical of each compartment 
which then simulates the digestion process in the 
gastrointestinal tract in humans (D'Antuono et 
al., 2015). When studying the influence of in vitro 
digestion on polyphenols, two important factors need 
to be considered which are oxygen and light as they 
can change the properties and structure of phenolic 
components, caused by oxidative reactions (Talcott 
and Howard, 1999). According to Bermúdez-
Soto and Tomás-Barberán (2004), in vitro systems 
with less levels of oxygen may be a more accurate 
representation of physiological conditions in the 
stomach and small intestine rather than digestion 
conducted in open-air flasks.
Table 2. Percentage bioaccessibility of apigenin in 
Water Lily mango pulp extract (WLPE) after in vitro 
gastrointestinal digestion.
Digestion phase % bioaccessibility (recovery) % loss
Gastric juice 20.26 ± 3.06a 79.74 ± 3.06a
Intestinal juice 41.53 ± 13.99b 58.47 ± 13.99b
Data are means of three determinations (n = 3) ± standard deviation. 
Different letters in the same column indicate significant differences (p 
< 0.05).
Bioaccessibility of apigenin 
Table 2 shows the detailed bioaccessible 
percentages of apigenin compound following in vitro 
gastrointestinal digestion. The results demonstrate 
that after 1 h of exposure to gastric environment, 
the bioaccessibility of apigenin was 20.26 ± 3.06%, 
with 79.74 ± 3.06% losses during the digestion. The 
transition from the acidic gastric to the mild alkaline 
intestinal condition caused a significant increase in the 
percent recovery of apigenin, with 41.53 ± 13.99% of 
bioaccessibility and 58.47 ± 13.99% losses.
In the present work, a decreasing trend in 
bioaccessibility in apigenin after digestion with pepsin 
could be due to the low stability of this compound in 
gastric environment. Mosele et al. (2015) stated that 
the chemical structure of the phenolic compounds 
as well as their stability during simulated digestion 
can affect these kinds of results. The bioaccessibility 
of apigenin after 2 h in intestinal condition 
demonstrated a higher recovery percentage since its 
solubility increased in mild alkaline environment and 
observed to be 2-fold higher than the gastric phase. 
Losses during gastrointestinal digestion could be 
due to the changes in pH between these two phases 
and interaction with other components, which differ 
in their chemical structures (Krook and Hagerman, 
2012; Velderrain-Rodríguez et al., 2016).
Figure 3. Amount of apigenin in Water Lily mango pulp 
extract (WLPE) and bioaccessible fraction after gastric 
and intestinal in vitro digestion. Data are means of three 
determinations (n = 3) with bars indicating standard 
deviation.
1632 Marina, Z., Amin, I., Loh, S. P., Fadhilah, J. and Kartinee, K./IFRJ 26(5) : 1627-1634
In agreement with these findings, Weathers et al. 
(2014) stated that the bioaccessibility of flavonoids 
extracted from Artemisia annua leaves was higher 
in the intestinal phase than its amount at the end 
of the gastric digestion phase. Chandrasekara and 
Shahidi (2012) also reported a similar trend after 
a gastrointestinal digestion of different varieties 
of grains. A study by Velderrain-Rodríguez et al. 
(2016) revealed that the bioaccessibility of phenolic 
compounds in mango was stable with about 50% of 
its total polyphenols during the gastric and intestinal 
phases. However, a study by Lingua et al. (2018) 
observed a decrease in bioaccessible polyphenols 
during intestinal digestion. This could be associated 
with the pH changes along the gastrointestinal 
digestion, as the phenolic compounds are unstable in 
a neutral or alkaline condition but resistant to gastric 
environment (Arenas and Trinidad, 2017; Burgos-
Edwards et al., 2017). 
Conclusion 
From the results obtained in the present 
work, it is possible to conclude that the apigenin 
compound from Water Lily mango pulp extract 
was more accessible in the intestinal digestion by 
using the in vitro digestion model, thus indicating 
the possibility of absorption in the small intestine, 
which can lead to the beneficial relation between 
mango consumption and health-related outcomes. 
Losses mostly occurred during gastric digestion, 
suggesting that the bioaccessible apigenin was more 
stable in an intestinal environment as compared to 
an acidic gastric condition, and this could be due to 
the difference in pH and enzymes involved in both 
digestion phases. For further investigations, the 
bioavailability of apigenin fraction should be carried 
out to determine whether it is available or susceptible 
to be absorbed in the upper gastrointestinal tract, 
subsequently passing through biological membranes, 
then entering the systemic circulation to exert a 
specific biological activity.
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